Company news
Scivision Biotech Inc. (TWSE:1786) news
Scivision Biotech Inc. news releases on 6ix. Latest, Aug 15, 2022: SciVision Biotech : Announcement of the approval for recordation being granted by FSC…
Press releases & updates
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds
August 15, 2022
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months
August 11, 2022
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022
August 3, 2022
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.
June 29, 2022
SciVision Biotech : Announce the record date for cash dividend
June 29, 2022
SciVision Biotech : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders
June 29, 2022
SciVision Biotech : The Company’s Product, hyaluronic acid Flexotron Forte (1%) has obtained medical device license.
June 9, 2022
SciVision Biotech : The The Company’s Product, hyaluronic acid three-injection linear intra-articular implant, Flexotron Plus (2%) has obtained medical device license.
May 26, 2022
SciVision Biotech : The Company's Board of Directors resolved the dividend distributions
March 23, 2022
SciVision Biotech : Board of Directors approved the convening of the 2022 Annual Shareholders' Meeting
March 23, 2022
SciVision Biotech : The Company's 2021 consolidated financial statements have been approved by the Board of Directors
March 23, 2022